SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of report (Date of earliest
event reported): January 29, 2013
IDEXX LABORATORIES, INC.
(Exact name of registrant as specified
in its charter)
|(State or other jurisdiction
||(Commission File Number)
||(IRS Employer Identification No.)|
|One IDEXX Drive, Westbrook, Maine
|(Address of principal executive offices)
(Registrant's telephone number, including
(Former name or former address, if changed
since last report)
|Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. to Form 8-K):|
||Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)|
||Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)|
||Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))|
||Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 2.02 Results of Operations
and Financial Condition.
On January 29, 2013, IDEXX Laboratories,
Inc. (the “Company”) announced its financial results for the quarter and year ended December 31, 2012. The full text
of the press release issued in connection with the announcement is furnished as Exhibit 99.1 to this Current Report on Form 8-K.
In accordance with general instructions
to Form 8-K, the information in this Form 8-K and the Exhibit 99.1 attached hereto is being furnished under Item 2.02 and shall
not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”)
or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the
Securities Act of 1933 or the Exchange Act, except as expressly set forth by specific reference in such a filing.
Item 9.01 Financial Statements and Exhibits.
The following exhibit relating
to Item 2.02 shall be deemed to be furnished, and not filed.
|99.1||Press Release entitled “IDEXX Laboratories Announces Fourth Quarter and Full-Year Financial
Results,” issued by the company on January 29, 2013.|
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
||IDEXX LABORATORIES, INC.|
|Date: January 29, 2013
||/s/ Merilee Raines|
||Executive Vice President, Chief Financial Officer and Treasurer|
||Description of Exhibit|
||Press Release entitled “IDEXX Laboratories Announces Fourth Quarter and Full-Year Financial Results,” issued by the company on January 29, 2013.|